Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity
Abstract Background Hepatitis B virus (HBV) infection is difficult to cure. HBV-specific immune tolerance plays a key role in HBV persistence, and enhancing cellular and humoral immunity will improve the control of HBV infection. The purpose of the study was to explore the anti-HBV and immunostimula...
Main Authors: | Tingyu Lan, Zhiqiang Wei, Yulin He, Song Wan, Li Liu, Bin Cheng, Ruimin Li, Hongxia Chen, Guohua Liu, Zhongji Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12985-021-01509-z |
Similar Items
-
Nanoparticles and siRNA: A new era in therapeutics?
by: María Dolores Pérez-Carrión, et al.
Published: (2024-03-01) -
Molecular Properties, Functional Mechanisms, and Applications of Sliced siRNA
by: Guihua Sun, et al.
Published: (2015-01-01) -
Implications of siRNA Therapy in Bone Health: Silencing Communicates
by: Puneetpal Singh, et al.
Published: (2024-01-01) -
SiRNA silencing efficacy prediction based on a deep architecture
by: Ye Han, et al.
Published: (2018-09-01) -
Biochemistry-informed design selects potent siRNAs against SARS-CoV-2
by: Élisabeth Houbron, et al.
Published: (2023-12-01)